Incidence and characteristics of clinical and sub-clinic hyperthyroidism;Incidencia y características del hipertiroidismo clínico y subclínico

Atencion Primaria

Volumn 32, Issue 4, 2003, Pages 203-207

  Soler Solé, M Neus ^a,d   Godoy, P ^b   Amoros Brotons M ^a   Sarriegui Dominguez S ^a   Rius Riu, F ^c  

^a Medicina de Familia   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c HOSPITAL ARNAU DE VILANOVA   (Spain)

^d INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

Antithyroglobulin (anti Tg) antibodies. Antithyroid microsomal (TPO) antibodies; Thyroid stimulating hormone (TSH); Thyroxine (T4); Triiodothyronine (T3)

Indexed keywords

IODINE; LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH SERVICE; HUMAN; HYPERTHYROIDISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RETROSPECTIVE STUDY;

HUMANS; HYPERTHYROIDISM; INCIDENCE; IODINE; RETROSPECTIVE STUDIES;

EID: 0345257215     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13051021     Document Type: Article

References (18)

1. Serra M, Méndez M, Davins AJ, Borrell M, Baxarias J, Rios L. Patología tiroidea en un centro de salud. Aten Primaria 1995;15:457-60.
2. Gascó Eguiluz E, Serna Arcaiz MC, Vázquez Torguet A, Peremiquel Lluch M, Ibarz Escurre M, Serra L. Prevalencia de trastorno de la función tiroidea en la provincia de Lleida. Aten Primaria 1999;24:475-9.
3. Torroba Arlegui I, Puigdevall Gallego V, Laudo Parods D, San Martín Barrio L. Disfunción tiroidea subclínica en atención primaria. Aten Primaria 1998;21:245-9.
4. Vanderpump MP, Tunbridge M. The epidemiology of thyroid diseases. Lippincott-Raven 1996; p. 474-5.
5. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whíckham Survey. Clin Endocrinol 1995;43:55-68.
6. Serna Arnaiz MC, Serra i Majem L, Gascó Eguiluz E, Muñoz Márquez J, Ribas L, Escobar del Rey F. Situación actual de la endemia de bocio y del consumo del yodo en la población del Pirineo y de la comarca del Segrià de Lleida. Aten Primaria 1998;22:642-8.
7. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol 1991;34:77-83.
8. Weber PM, Feldman R, Schurr DA, Timothy G. Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch Intern Med 1980;140:1045-9.
9. Eggertsen R, Petersen K, Lundberg PA, Nyström E, Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. BMJ 1988;297:1586-91.
10. Diaz Cadórniga FJ. Problemática del déficit de yodo en España. Aten Primaria 2000;26(Supl 1):116-8.
11. Ayala C, Cózar MV, Rodríguez JR, Silva H, Pereira JL, García-Luna PP. Enfermedad tiroidea subclínica en la población anciana sana institucionalizada. Med Clin (Barc) 2001;117:534-5.
12. Gómez de la Torre R, Otero Diez J, Rubio Barbón S. Hipertiroidismo subclínico. Rev Clin Esp 2001;201:40-2.
13. Gómez de la Torre R, Enguix Armada A, García L, Otero Díez J. Estudio de la enfermedad nodular tiroidea en una zona previamente bodiógena. An Med Interna 1993;10:487-9.
14. Barriales Álvarez V, Morís de la Taza C, Sánchez Posada I, Barriales Villa R, Rubin López J. The etiology and associated risk factors in a sample of 300 patients with atrial fibrillation. Rev Esp Cardiol 1999;52:403-14.
15. Mostbeck A, Galván G, Bauer P, Eber O, Atefie K, Dam K. The incidence of hyperthyroidism in Austria from 1987 or 1995 before and after an increase in salt ioditzation in 1990. Eur J Nuclear Med 1998;25:367-74.
16. Eggertsen R, Pertesen K, Lumberg PA, Nystrom E, Linsdtedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. BMJ 1988;297:1586-92.
17. Utiger RD. Subclinical Hyperthyroidism-just a low serum thyrotropin concentration, or something more? N Engl J Med 1994;331:1302-3.
18. Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with 1-thyroxine. Am J Med 1987;82:1167.